BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 22302620)

  • 21. Prediction of type 2 diabetes: the dawn of polygenetic testing for complex disease.
    Meigs JB
    Diabetologia; 2009 Apr; 52(4):568-70. PubMed ID: 19214469
    [No Abstract]   [Full Text] [Related]  

  • 22. Exploring lifestyle and risk in preventing type 2 diabetes-a nested qualitative study of older participants in a lifestyle intervention program (VEND-RISK).
    Følling IS; Solbjør M; Midthjell K; Kulseng B; Helvik AS
    BMC Public Health; 2016 Aug; 16(1):876. PubMed ID: 27557801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The reporting of previous lifestyle counseling by persons at high risk of Type 2 diabetes.
    Salmela SM; Vähäsarja K; Villberg J; Vanhala M; Saaristo T; Lindström J; Oksa H; Korpi-Hyövälti E; Niskanen L; Keinänen-Kiukaanniemi S; Poskiparta M
    Patient Educ Couns; 2012 May; 87(2):178-85. PubMed ID: 21943790
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Health improvement and prevention study (HIPS) - evaluation of an intervention to prevent vascular disease in general practice.
    Fanaian M; Laws RA; Passey M; McKenzie S; Wan Q; Davies GP; Lyle D; Harris MF
    BMC Fam Pract; 2010 Aug; 11():57. PubMed ID: 20687956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cost-effectiveness of a lifestyle intervention in high-risk individuals for diabetes in a low- and middle-income setting: Trial-based analysis of the Kerala Diabetes Prevention Program.
    Sathish T; Oldenburg B; Thankappan KR; Absetz P; Shaw JE; Tapp RJ; Zimmet PZ; Balachandran S; Shetty SS; Aziz Z; Mahal A
    BMC Med; 2020 Sep; 18(1):251. PubMed ID: 32883279
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type-2 diabetes primary prevention program implemented in routine primary care: a process evaluation study.
    Sánchez A; Silvestre C; Campo N; Grandes G;
    Trials; 2016 May; 17(1):254. PubMed ID: 27206733
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Implementation of a lifestyle intervention for type 2 diabetes prevention in Dutch primary care: opportunities for intervention delivery.
    Vermunt PW; Milder IE; Wielaard F; Baan CA; Schelfhout JD; Westert GP; van Oers HA
    BMC Fam Pract; 2012 Aug; 13():79. PubMed ID: 22873753
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Computer-supported indirect-form lifestyle-modification support program using Lifestyle Intervention Support Software for Diabetes Prevention (LISS-DP) for people with a family history of type 2 diabetes in a medical checkup setting: a randomized controlled trial.
    Tokunaga-Nakawatase Y; Nishigaki M; Taru C; Miyawaki I; Nishida J; Kosaka S; Sanada H; Kazuma K
    Prim Care Diabetes; 2014 Oct; 8(3):207-14. PubMed ID: 24529485
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genomic counseling: next generation counseling.
    Mills R; Haga SB
    J Genet Couns; 2014 Aug; 23(4):689-92. PubMed ID: 24026254
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lifestyle Change Plus Dental Care (LCDC) program improves knowledge, attitude, and practice (KAP) toward oral health and diabetes mellitus among the elderly with type 2 diabetes.
    Saengtipbovorn S; Taneepanichskul S
    J Med Assoc Thai; 2015 Mar; 98(3):279-90. PubMed ID: 25920299
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Patient beliefs and behaviors about genomic risk for type 2 diabetes: implications for prevention.
    Gallagher P; King HA; Haga SB; Orlando LA; Joy SV; Trujillo GM; Scott WM; Bembe M; Creighton DL; Cho AH; Ginsburg GS; Vorderstrasse A
    J Health Commun; 2015; 20(6):728-35. PubMed ID: 25844569
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Real world experience with cancer genetic counseling via telephone.
    Sutphen R; Davila B; Shappell H; Holtje T; Vadaparampil S; Friedman S; Toscano M; Armstrong J
    Fam Cancer; 2010 Dec; 9(4):681-9. PubMed ID: 20799063
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type 2 diabetes prevention in the "real world": one-year results of the GOAL Implementation Trial.
    Absetz P; Valve R; Oldenburg B; Heinonen H; Nissinen A; Fogelholm M; Ilvesmäki V; Talja M; Uutela A
    Diabetes Care; 2007 Oct; 30(10):2465-70. PubMed ID: 17586741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of a Behavioral Intervention Strategy on Sustained Change in Physical Activity and Sedentary Behavior in Patients With Type 2 Diabetes: The IDES_2 Randomized Clinical Trial.
    Balducci S; D'Errico V; Haxhi J; Sacchetti M; Orlando G; Cardelli P; Vitale M; Bollanti L; Conti F; Zanuso S; Lucisano G; Nicolucci A; Pugliese G;
    JAMA; 2019 Mar; 321(9):880-890. PubMed ID: 30835309
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Operationalizing the Reciprocal Engagement Model of Genetic Counseling Practice: a Framework for the Scalable Delivery of Genomic Counseling and Testing.
    Schmidlen T; Sturm AC; Hovick S; Scheinfeldt L; Scott Roberts J; Morr L; McElroy J; Toland AE; Christman M; O'Daniel JM; Gordon ES; Bernhardt BA; Ormond KE; Sweet K
    J Genet Couns; 2018 Sep; 27(5):1111-1129. PubMed ID: 29460110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained diabetes risk reduction after real life and primary health care setting implementation of the diabetes in Europe prevention using lifestyle, physical activity and nutritional intervention (DE-PLAN) project.
    Gilis-Januszewska A; Lindström J; Tuomilehto J; Piwońska-Solska B; Topór-Mądry R; Szybiński Z; Peltonen M; Schwarz PE; Windak A; Hubalewska-Dydejczyk A
    BMC Public Health; 2017 Feb; 17(1):198. PubMed ID: 28202029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Genetics of diabetes mellitus: what kind of counseling for which patients?].
    Philippe J; Schönle E
    Schweiz Med Wochenschr Suppl; 1994; 60():67-70. PubMed ID: 8016616
    [No Abstract]   [Full Text] [Related]  

  • 39. Prevention of diabetes and cardiovascular diseases in occupational health care: feasibility and effectiveness.
    Viitasalo K; Hemiö K; Puttonen S; Hyvärinen HK; Leiviskä J; Härmä M; Peltonen M; Lindström J
    Prim Care Diabetes; 2015 Apr; 9(2):96-104. PubMed ID: 25128324
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Family history of diabetes and effectiveness of lifestyle counselling on the cardio-metabolic risk profile in individuals at high risk of Type 2 diabetes: 1-year follow-up of the FIN-D2D project.
    Rautio N; Jokelainen J; Oksa H; Saaristo T; Peltonen M; Puolijoki H; Tuomilehto J; Vanhala M; Moilanen L; Uusitupa M; Keinänen-Kiukaanniemi S
    Diabet Med; 2012 Feb; 29(2):207-11. PubMed ID: 21781153
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.